← back to search

Jue Wang

Fujian Medical University · CN
Area of research
Surgery · Pharmacology
Research interest
Research interests include Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Biological and pharmacological studies of plants, and Cancer Immunotherapy and Biomarkers.
h-index
19
citations
1,197
works
95
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Distinct Roles of Matrigel Enabled the Production of Expandable Hepatoblast and Polarized Hepatocyte Organoids from Human Embryonic Stem Cells under 3-Dimensional Suspension Conditions
Biomaterials Research 2025cited by 1position: middledoi
Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial Cancer
Journal of Clinical Oncology 2020cited by 133position: middledoi
Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association with Clinical Outcomes: A Pilot Study
European Urology Oncology 2019cited by 48position: middledoi
Randomized double-blind phase II study of maintenance pembrolizumab versus placebo after first-line chemotherapy in patients (pts) with metastatic urothelial cancer (mUC): HCRN GU14-182.
Journal of Clinical Oncology 2019cited by 25position: middledoi
Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA
Cancer 2018cited by 100position: middledoi
Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas
Oncotarget 2015cited by 44position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Sumati Gupta · University of Utah4 papers (2018–2020)Sumanta K. Pal · City of Hope3 papers (2018–2020)Long H. Dang · Shanxi Medical University2 papers (2019–2020)George Philips · Georgetown University2 papers (2019–2020)Neeraj Agarwal · University of Utah2 papers (2018–2019)Noah M. Hahn · University Hospital Regensburg2 papers (2019–2020)Gurudatta Naik · University of Alabama at Birmingham2 papers (2018–2019)Richard B. Lanman · C.T. de Wit Graduate School for Production Ecology and Resource Conservation2 papers (2018–2019)Petros Grivas · Second Foundation (United States)2 papers (2018–2019)Radhika Walling · Unity Hospital2 papers (2019–2020)David I. Quinn · AbbVie (United States)2 papers (2019–2020)Daniel M. Geynisman · National Cancer Institute2 papers (2019–2020)Amir Mortazavi · The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute2 papers (2019–2020)Joel Picus · Sidney Kimmel Comprehensive Cancer Center2 papers (2019–2020)Bishoy M. Faltas · Cornell University2 papers (2018–2019)Gregory R. Pond · Université Claude Bernard Lyon 12 papers (2018–2019)Alexandra Drakaki · University of Colorado Denver2 papers (2018–2019)Guru Sonpavde · AdventHealth Orlando2 papers (2018–2019)Dharmesh Gopalakrishnan · Roswell Park Comprehensive Cancer Center2 papers (2018–2019)Pedro C. Barata · Southwestern Medical Center2 papers (2018–2019)